Editorial on Screening for Lung Cancer by Sateia et al

In their review article, Satiea et al. discuss the burden of lung cancer and the potential benefits and harms of low-dose CT (LDCT) lung cancer screening [1]. As lung cancer is the most common cause of cancer mortality in the developing world, the promise of a mortality reduction on the order of 15-20% among those undergoing screening, as observed in the National Lung Screening Trial (NLST), is alluring. However, for the potential of LDCT screening to be optimized, the harms must be minimized and screening must be effectively targeted to persons both at high risk and also able to benefit from curative treatments.

Source: Seminars in Oncology - February 7, 2017 Category: Cancer & Oncology Authors: Paul F. Pinsky Source Type: research